How Big is the Neurovascular Devices Market?
The global neurovascular devices market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.14% during 2024-2032.
Factors Affecting the Growth of the Neurovascular Devices Industry:
- Expansion of Healthcare Infrastructure:
The expansion of healthcare infrastructure globally, particularly in emerging economies, plays a crucial role in the growth of the neurovascular devices industry. Improved healthcare facilities, coupled with increasing investments in the healthcare sector, facilitate the adoption of advanced medical technologies, including neurovascular devices. This expansion is supported by government initiatives aimed at enhancing healthcare accessibility and quality, which include funding for state-of-the-art medical equipment and training for healthcare professionals. As a result, there is a wider availability of sophisticated neurovascular treatments, leading to increased usage of neurovascular devices in hospitals and clinics, thereby propelling the growth of the industry by ensuring these critical tools are more accessible to patients worldwide.
- Increasing Incidence of Neurovascular Disorders:
The growth of the neurovascular devices industry is closely tied to the rising prevalence of neurovascular conditions, such as strokes, aneurysms, and arteriovenous malformations. As the global population ages, the incidence of these disorders escalates, creating a higher demand for effective and timely neurovascular interventions. This demographic shift, coupled with growing awareness of the critical nature of addressing neurovascular issues promptly, encourages healthcare providers to adopt advanced neurovascular devices. Consequently, this trend ensures a consistent demand for innovative and reliable solutions, thereby fueling the expansion of the industry and fostering advancements in neurovascular treatment and management.
- Technological Advancements:
The neurovascular devices industry is significantly propelled by ongoing technological innovations. Breakthroughs in device engineering, such as enhanced stent retrievers, flow diverters, and intrasaccular devices, are revolutionizing stroke treatment and aneurysm management. These advancements improve procedural outcomes and expand the treatable patient demographic by offering solutions for previously inoperable conditions. The development of biocompatible materials and imaging technologies further supports precise and safer neurovascular interventions, thereby driving industry growth by broadening the spectrum of therapeutic applications and increasing the global demand for these state-of-the-art devices.
For an in-depth analysis, you can refer sample copy of the report : https://www.imarcgroup.com/neurovascular-devices-market/requestsample
Leading Companies Operating in the Global Neurovascular Devices Industry:
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- Imperative Care Inc.
- Integer Holdings Corporation
- Johnson & Johnson
- Medtronic plc
- MicroPort Scientific Corporation
- Penumbra Inc.
- Perflow Medical Ltd.
- Rapid Medical
- Stryker Corporation
- Terumo Corporation
- Neurovascular Devices Market Report Segmentation:
By Product:
- Cerebral Embolization and Aneurysm Coiling Devices
- Embolic Coils
- Flow Diverters
- Liquid Embolic Agents
- Cerebral Angioplasty and Stenting Systems
- Carotid Artery Stents
- Embolic Protection Devices
- Neurothrombectomy Devices
- Clot Retrieval Devices
- Suction Devices
- Vascular Snares
- Support Devices
- Micro Catheters
- Micro Guidewires
Cerebral embolization and aneurysm coiling devices dominate the market due to the high prevalence of cerebral aneurysms and the widespread adoption of these devices for minimally invasive endovascular procedures, offering effective, safe, and timely intervention.
By Application:
- Ischemic Stroke
- Aneurysm
- Arteriovenous Malformation and Fistulas (AVM)
- Stenosis
- Others
Based on the application, the market has been classified into ischemic stroke, aneurysm, arteriovenous malformation and fistulas (AVM), stenosis, and others.
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
Hospitals represent the largest segment as they are the main settings for neurovascular procedures, equipped with the necessary infrastructure, specialized staff, and technology to perform complex interventions.
Regional Insights:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
North America's dominance in the neurovascular devices market is attributed to its advanced healthcare infrastructure, high healthcare expenditure, strong presence of leading device manufacturers, and a growing patient population requiring neurovascular interventions.
Global Neurovascular Devices Market Trends:
The global neurovascular devices market is witnessing robust growth, propelled by the rising prevalence of neurovascular diseases and the aging population. Technological advancements are at the heart of the expansion of the market, introducing innovative products like flow diverters, stent retrievers, and embolic coils that offer enhanced efficacy and safety.
There is a significant uptick in demand for minimally invasive surgical procedures, driving the adoption of these devices due to their benefits of reduced recovery times and lower complication risks. Additionally, increasing healthcare expenditure and growing awareness about neurovascular disorders are fueling the growth of the market, ensuring a steady rise in the adoption of neurovascular interventions worldwide.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Browse Other Research Reports :
Macular Degeneration Treatment Market Report by Type (Dry Age-related Macular Degeneration, Wet Age-related Macular Degeneration), Stage of Disease (Early Stage, Intermediate Stage, Late Stage), Route of Administration (Intravenous Route, Intravitreal Route), End User (Hospitals, Ambulatory Surgical Center, and Others), and Region 2024-2032
Mucosal Atomization Devices Market Report by Product Type (Nasal Atomization Devices, Fiber-Optic Atomization Devices, Laryngo-Tracheal Atomization Devices, Bottle Atomizer Devices), Technology (Gas Propelled, Electrical), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Region 2024-2032
Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2024-2032
One Wheel Electric Scooter Market Report by Product (Electric Unicycle, Electric One Wheel Hoverboard), Speed Limit (20 Kmph - 30 Kmph, 30 Kmph - 50 Kmph, More than 50 Kmph), Distribution Channel (Online, Offline), Application (Off-road Activities, Daily Commute), and Region 2024-2032
